False Premise Underlies Trump’s ‘Freeloading’ Drug Cost Pitch

A former FDA associate commissioner and former Republican state senator who oppose importing international reference pricing to lower U.S. drug prices say U.S. trade policy should use economic measures like gross national income (GNI) per capita to crack down on countries that are “freeloading” on American drug innovation.